{
    "initial_scores": {
        "ideological_tilt": 4,
        "immigration": 0,
        "executive_power": 0,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 4,
        "social_inclusion": 0
    },
    "critique": "This document focuses on lowering prescription drug costs through government action, primarily by implementing and complementing the Inflation Reduction Act (IRA). It directs the Secretary of HHS to consider new healthcare payment models to lower drug costs within Medicare and Medicaid. The document doesn't directly address immigration, executive power, federalism, national security, or social inclusion. It leans towards government intervention in the economy to regulate drug prices. The ideological tilt is liberal, as it advocates for government intervention to lower drug costs and expand access to healthcare. There is no impact on civil liberties. The document does not expand executive power, as it directs the Secretary of HHS to take actions within existing legal frameworks. It does not shift power between the federal and state governments. It does not address social inclusion.",
    "revised_scores": {
        "ideological_tilt": 4,
        "immigration": 0,
        "executive_power": 0,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 4,
        "social_inclusion": 0
    }
}